AstraZeneca (AZN -0.9%) forges a deal to co-develop a novel cancer treatment from Hutchison...

|About: AstraZeneca Group plc (AZN)|By:, SA News Editor

AstraZeneca (AZN -0.9%) forges a deal to co-develop a novel cancer treatment from Hutchison China MediTech (HNCMF.PK) and buys options on diabetes pills from Astellas Pharma (ALPMY.PK). The products are at an early stage and won't do much to calm concerns about AZN's thin pipeline, especially after yesterday's setback.